Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine
Department of Epidemiology, University of North Carolina, and Smith-Kline-Beecham
Department of Clinical Psychology, Max Planck Institute of Psychiatry Clinical Institute
World Health Organization
Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
Declaration of interest Funding received from the National Institute of Mental Health, the National Institute of Drug Abuse, the W.T.Grant Foundation and SmithKline Beecham Pharmaceuticals.
Address comments or questions about the NCS data set to:R.C. Kessler,
Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue,
Boston, MA 02115, USA. Tel: (617) 432-3587; fax: (617) 432-3588. See
Acknowledgements for instructions on how to obtain a complete list of NCS
documents and a copy of the NCS public use data tape from the Internet.
Correspondence: Peter Roy-Byrne, Professor and Vice-Chairman, Department of Psychiatry, University of Washington at Harborview Medical Center, 325 9th Avenue, Box 35911, Seattle, WA 98104, USA. Tel: (206) 731-3404; fax: (206) 731-3236
Background Most prior studies of panic-depression comorbidity have
been limited methodologically by use of small clinical samples and incomplete
analyses.
Aims General population data were used to study the association of lifetime and recent (12 months) panic-depression comorbidity with symptom severity, impairment, course and help-seeking in the National Comorbidity Survey (NCS).
Method The NCS is a nationally representative survey of the prevalences and correlates of major DSM-III-R disorders in the US household population.
Results Strong lifetime and current comorbidity were found between panic and depression. Comorbidity was associated with greater symptom severity, persistence, role impairment, suicidality and help-seeking, with many findings persisting after controlling for additional comorbid diagnoses. Findings did not differ according to which disorder was chronologically primary.
Conclusions Both lifetime and current panic-depression comorbidity are markers for more severe, persistent and disabling illness. Neither additional comorbid diagnoses nor the primary-secondary distinction were important moderators of these associations.
This article has been cited by other articles:
![]() |
C. B. Bringager, K. Gauer, H. Arnesen, S. Friis, and T. Dammen Nonfearful Panic Disorder in Chest-Pain Patients: Status After Nine-Year Follow-Up Psychosomatics, September 1, 2008; 49(5): 426 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Smolders, M. Laurant, E. van Rijswijk, J. Mulder, J. Braspenning, P. Verhaak, M. Wensing, and R. Grol The impact of co-morbidity on GPs' pharmacological treatment decisions for patients with an anxiety disorder Fam. Pract., December 1, 2007; 24(6): 538 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. G. Cameron, G. C. Huang, T. Nichols, R. A. Koeppe, S. Minoshima, D. Rose, and K. A. Frey Reduced {gamma}-Aminobutyric AcidA-Benzodiazepine Binding Sites in Insular Cortex of Individuals With Panic Disorder Arch Gen Psychiatry, July 1, 2007; 64(7): 793 - 800. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Moffitt, H. Harrington, A. Caspi, J. Kim-Cohen, D. Goldberg, A. M. Gregory, and R. Poulton Depression and Generalized Anxiety Disorder: Cumulative and Sequential Comorbidity in a Birth Cohort Followed Prospectively to Age 32 Years Arch Gen Psychiatry, June 1, 2007; 64(6): 651 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Dolnak Treating Patients for Comorbid Depression, Anxiety Disorders, and Somatic Illnesses J Am Osteopath Assoc, May 1, 2006; 106(5_suppl_2): S1 - S8. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Kunen, C Prejean, B Gladney, D Harper, and C V Mandry Disposition of emergency department patients with psychiatric comorbidity: results from the 2004 National Hospital Ambulatory Medical Care Survey. Emerg. Med. J., April 1, 2006; 23(4): 274 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Kessler, W. T. Chiu, R. Jin, A. M. Ruscio, K. Shear, and E. E. Walters The epidemiology of panic attacks, panic disorder, and agoraphobia in the national comorbidity survey replication. Arch Gen Psychiatry, April 1, 2006; 63(4): 415 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Arnow, E. M. Hunkeler, C. M. Blasey, J. Lee, M. J. Constantino, B. Fireman, H. C. Kraemer, R. Dea, R. Robinson, and C. Hayward Comorbid depression, chronic pain, and disability in primary care. Psychosom Med, March 1, 2006; 68(2): 262 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Baldwin, I. M. Anderson, D. J. Nutt, B. Bandelow, A. Bond, J. R. T. Davidson, J. A. den Boer, N. A. Fineberg, M. Knapp, J. Scott, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J Psychopharmacol, November 1, 2005; 19(6): 567 - 596. [Abstract] [PDF] |
||||
![]() |
J. Sareen, B. J. Cox, T. O. Afifi, R. de Graaf, G. J. G. Asmundson, M. ten Have, and M. B. Stein Anxiety Disorders and Risk for Suicidal Ideation and Suicide Attempts: A Population-Based Longitudinal Study of Adults Arch Gen Psychiatry, November 1, 2005; 62(11): 1249 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Roy-Byrne, M. G. Craske, M. B. Stein, G. Sullivan, A. Bystritsky, W. Katon, D. Golinelli, and C. D. Sherbourne A Randomized Effectiveness Trial of Cognitive-Behavioral Therapy and Medication for Primary Care Panic Disorder Arch Gen Psychiatry, March 1, 2005; 62(3): 290 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Goodwin, R. Lieb, M. Hoefler, H. Pfister, A. Bittner, K. Beesdo, and H.-U. Wittchen Panic Attack as a Risk Factor for Severe Psychopathology Am J Psychiatry, December 1, 2004; 161(12): 2207 - 2214. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Grant, F. S. Stinson, D. A. Dawson, S. P. Chou, M. C. Dufour, W. Compton, R. P. Pickering, and K. Kaplan Prevalence and Co-occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions Arch Gen Psychiatry, August 1, 2004; 61(8): 807 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. FRIEDLANDER, S. R. MARDER, E. C. SUNG, and J. S. CHILD Panic disorder: Psychopathology, medical management and dental implications J Am Dent Assoc, June 1, 2004; 135(6): 771 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Huffman and M. H. Pollack Predicting Panic Disorder Among Patients With Chest Pain: An Analysis of the Literature Psychosomatics, June 1, 2003; 44(3): 222 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. de Graaf, R. V. Bijl, F. Smit, W. A.M. Vollebergh, and J. Spijker Risk Factors for 12-Month Comorbidity of Mood, Anxiety, and Substance Use Disorders: Findings From the Netherlands Mental Health Survey and Incidence Study Am J Psychiatry, April 1, 2002; 159(4): 620 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rotondo, C. Mazzanti, L. Dell'Osso, P. Rucci, P. Sullivan, S. Bouanani, C. Gonnelli, D. Goldman, and G. B. Cassano Catechol O-Methyltransferase, Serotonin Transporter, and Tryptophan Hydroxylase Gene Polymorphisms in Bipolar Disorder Patients With and Without Comorbid Panic Disorder Am J Psychiatry, January 1, 2002; 159(1): 23 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. MacKinnon, P. P. Zandi, J. Cooper, J. B. Potash, S. G. Simpson, E. Gershon, J. Nurnberger, T. Reich, and J. R. DePaulo Comorbid Bipolar Disorder and Panic Disorder in Families With a High Prevalence of Bipolar Disorder Am J Psychiatry, January 1, 2002; 159(1): 30 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. GRUCZA Anxiety in Major Depression Am J Psychiatry, September 1, 2001; 158(9): 1535 - 1535. [Full Text] [PDF] |
||||
![]() |
R. Goodwin, D. A. Stayner, M. J. Chinman, and L. Davidson Impact of Panic Attacks on Rehabilitation and Quality of Life Among Persons With Severe Psychotic Disorders Psychiatr Serv, July 1, 2001; 52(7): 920 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Mellman, A. L. Miller, E. M. Weissman, M. L. Crismon, S. M. Essock, and S. R. Marder Evidence-Based Pharmacologic Treatment for People With Severe Mental Illness:A Focus on Guidelines and Algorithms Psychiatr Serv, May 1, 2001; 52(5): 619 - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
Comorbid Panic - Depression Is Linked to More Severe Illness Journal Watch Psychiatry, May 1, 2000; 2000(501): 4 - 4. [Full Text] |
||||